It starts with something that feels exciting. An email lands in your inbox claiming you may be entitled to an inheritance. No warning. No backstory. Just a formal message and a ticking clock. That is ...

Scammers are sending realistic inheritance emails that claim you must act within 48 hours The “Heir Research Registry” is not real, and the message lacks verifiable legal details Clicking the link can ...

Add Yahoo as a preferred source to see more of our stories on Google. Sting says he’s not leaving a penny to his kids — and he’s not the only star taking a tough love approach about money! “The worst ...

OpenAI’s latest voice AI model, GPT Realtime 2, introduces advanced capabilities for natural and context-aware interactions. Built on the GPT-5-level reasoning framework, it handles complex tasks such ...

OpenAI has announced three new real-time voice and audio API models, giving developers more options for building live voice agents, translation tools, and speech-to-text apps. The new lineup includes ...

OpenAI has introduced three new audio models through its API, expanding its push into real-time voice AI for developers. The launch includes GPT-Realtime-2, GPT-Realtime-Translate, and ...

OpenAI explains in more detail what’s new with the GPT-5-class GPT-Realtime-2 voice model with reasoning: GPT‑Realtime‑2 is built for live voice interactions where the model keeps the conversation ...

Older Americans are sitting on $110 trillion of wealth. Their heirs might not get it anytime soon. Financial advisory firms like to talk about a looming event called “the great wealth transfer,” where ...

May 3 (Asia Today) --The family of Lee Jae-yong has completed payment of about 12 trillion won ($8.1 billion) in inheritance taxes over five years, marking the largest such payment in South Korean ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.